.png)
Latest Conference Articles
Please check back later for more content.
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
3
Off-Label Case Series: Topical Roflumilast for Mild HS
4
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
5